Prior Therapies for Erdafitinib

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.111
Version
20240216
PublisherCancerLinQ StewardDate2024-02-16T01:10:57-05:00Purpose

(Clinical Focus: Prior therapies for erdafitinib),(Data Element Scope: Rxnorm codes),(Inclusion Criteria: Bladder cancer therapies),(Exclusion Criteria: Paclitaxel poliglumex and doxorubicin liposome)

Expansion
<<>>>
CodeDisplaySystem
1547545http://www.nlm.nih.gov/research/umls/rxnorm
309311http://www.nlm.nih.gov/research/umls/rxnorm
1441418http://www.nlm.nih.gov/research/umls/rxnorm
236234http://www.nlm.nih.gov/research/umls/rxnorm
152200http://www.nlm.nih.gov/research/umls/rxnorm
331954http://www.nlm.nih.gov/research/umls/rxnorm
368138http://www.nlm.nih.gov/research/umls/rxnorm
93698http://www.nlm.nih.gov/research/umls/rxnorm
1921598http://www.nlm.nih.gov/research/umls/rxnorm
2268314http://www.nlm.nih.gov/research/umls/rxnorm
1111072http://www.nlm.nih.gov/research/umls/rxnorm
1669867http://www.nlm.nih.gov/research/umls/rxnorm
11199http://www.nlm.nih.gov/research/umls/rxnorm
197709http://www.nlm.nih.gov/research/umls/rxnorm
1669872http://www.nlm.nih.gov/research/umls/rxnorm
1244552http://www.nlm.nih.gov/research/umls/rxnorm
1921596http://www.nlm.nih.gov/research/umls/rxnorm
1544402http://www.nlm.nih.gov/research/umls/rxnorm
1720977http://www.nlm.nih.gov/research/umls/rxnorm
2637963http://www.nlm.nih.gov/research/umls/rxnorm